Ollainville, France

Nicolas Hebert


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Nicolas Hebert

Introduction

Nicolas Hebert is a notable inventor based in Ollainville, France. He has made significant contributions to the field of medical technology, particularly in the area of hematology. With a total of 2 patents, his work focuses on methods for analyzing hemoglobin content in erythroid cells.

Latest Patents

Nicolas Hebert's latest patents include two innovative methods that utilize flow cytometry. The first patent is a method for determining the hemoglobin content of an erythroid cell. This invention is particularly useful for assessing the hemoglobin levels in red blood cells, which is crucial for monitoring patients with conditions such as sickle cell disease or β-thalassemia. The second patent involves a method for determining the hemoglobin F (HbF) content of erythroid cells. Similar to the first, this method aids in evaluating the HbF levels in red blood cells and is also applicable in monitoring transfusions and treatment efficacy for patients suffering from specific blood disorders.

Career Highlights

Throughout his career, Nicolas Hebert has worked with esteemed institutions such as Université Paris Est Créteil Val De Marne and the Institut National de la Santé et de la Recherche Médicale. His experience in these organizations has allowed him to develop and refine his innovative methods, contributing to advancements in medical research and patient care.

Collaborations

Nicolas has collaborated with several professionals in his field, including France Noizat Pirenne and Marie Georgine Rakotoson. These collaborations have further enriched his research and development efforts, leading to impactful innovations in hematology.

Conclusion

Nicolas Hebert's contributions to medical technology through his patents demonstrate his commitment to improving patient outcomes in hematological conditions. His innovative methods for analyzing hemoglobin content are vital tools in modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…